You are viewing the site in preview mode

Skip to main content

Advertisement

Figure 3 | BMC Infectious Diseases

Figure 3

From: Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: Derivation of a clinical algorithm

Figure 3

Observed and expected adverse events (A) and mortality (B) within CURB65 class 3-5 (high risk patients). Observed and expected adverse events and mortality within CURB65 class 3-5 (high risk patients). A. Calibration of ProADM deciles and adverse events. B. Calibration of initial ProADM deciles and mortality.

Back to article page